Quarterly report pursuant to sections 13 or 15(d)

GENERAL

v2.3.0.11
GENERAL
3 Months Ended
Mar. 31, 2012
Notes to Financial Statements  
GENERAL

 

Amarantus BioSciences, Inc. (the “Company”) was incorporated on January 14, 2008 in the state of Delaware. The Company is a development stage biopharmaceutical drug development company dedicated to sourcing high-potential therapeutic platform technologies and aligning their development with complementary clinical-stage compounds to reduce overall enterprise risk. Through March 31, 2012, the Company has been primarily engaged in biotechnology research and development and raising capital.